Colorectal cancer ranks as the second most prevalent global malignancy and stands as the fourth leading cause of cancer-related deaths in the United States. The ability to accurately monitor rectal cancer treatment responses poses a significant challenge given the limitations of existing imaging modalities in confirming pathological complete response after chemoradiation. Non-invasive confirmation of complete response can offer improved quality of life, reduced medical costs, and decreased strain on the healthcare system for patients. Previous findings from our research group highlighted the potential of co-registered acoustic-resolution Photoacoustic Microscopy (ARPAM) and ultrasound (ARPAM/US) in monitoring treatment response, revealing the recovery of regular microvascular patterns in the tumor bed through photoacoustic microscopy in treatment responders. In this presentation, we introduce a second-generation compact and robust ARPAM/US system designed for monitoring rectal cancer treatment responses in an endoscopy unit suitable for repeated imaging. We will present a comparative analysis between normal tissue and tumor bed with and without residual tumor after chemoradiation.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.